Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec:61:114-119.
doi: 10.1016/j.coph.2021.09.005. Epub 2021 Sep 25.

Gastrointestinal manifestations and SARS-CoV-2 infection

Affiliations
Review

Gastrointestinal manifestations and SARS-CoV-2 infection

Antonio Pizuorno et al. Curr Opin Pharmacol. 2021 Dec.

Abstract

Since COVID-19 occurrence in late 2019, intense research efforts on an unprecedented scale have focused on the study of named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry mechanisms and clinical presentations. As for other coronaviruses, SARS-CoV-2 presents with extrarespiratory clinical manifestations such as diarrhea, nausea, vomiting, and abdominal pain which highlight that the gastrointestinal (GI) system as another viral target along with the typical presentations of COVID-19 which is characterized primarily by respiratory symptoms. The digestive system is involved in many systemic functions through the gut-brain axis and systemic immunity modulation. Therefore, the GI system plays an important role in the presentation of the disease, pathogenesis, and possibly treatment outcomes. This minireview summarizes recent work to study SARS-CoV-2 infection as it relates to comorbidities, GI symptoms. This will help to strategize the priorities in understanding the impact of the virus on outcomes in various aspects.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement Nothing declared.

Figures

Figure 1
Figure 1
Schematic SARS-CoV-2 infection and entry to the cells. Viral particle entry was mediated by ACE2 receptor and TMPRSS2 in the gut. Viral genome is released and then translated, replicated and transcribed so it can infected other cells and be excreted via exocytosis and stimulate the production of proinflammatory cytokines which will influence the immune response both in the gut and in the lung via the gut–lung axis. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; ACE2, angiotensin-converting enzyme 2; TMPRSS2, transmembrane serine protease 2.

References

    1. Helmy Y.A., Fawzy M., Elaswad A., Sobieh A., Kenney S.P., Shehata A.A. The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. J Clin Med. 2020;9:1225. doi: 10.3390/jcm9041225. - DOI - PMC - PubMed
    2. Authors acknowledge the importance of knowing previous coronavirus epidemics in the past but also emphasize different characteristics that make SARS-CoV-2 unique and the lack of information at the beginning of the pandemic.

    1. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K., Lau E., Wong J.Y., Xing X., Xiang N., Wu Y., Li C., Chen Q., Li D., Liu T., Zhao J., Liu M., Tu W., Feng Z. Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–1207. doi: 10.1056/NEJMoa2001316. - DOI - PMC - PubMed
    2. This study from the first datasets of patients in China, where the pandemic started, describes the epidemiology of the virus, how the virus disseminates from person to person esspecially via respiratory droplets but also opens the discussion for more ways to help in the transmission of the disease.

    1. Li H., Liu S.M., Yu X.H., Tang S.L., Tang C.K. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020;55:105951. doi: 10.1016/j.ijantimicag.2020.105951. - DOI - PMC - PubMed
    2. This study emphasizes the ways the SARS-Cov-2 attach to the ACE receptors in the lung but also on the gut which opens a new way for fecal-oral transmission, digestive disease and and extended description on the pathophysiology of COVID-19 with potential sites for treatment and vaccines.

    1. World Health Organization . 2020. WHO Director General opening remarks at the media briefing on COVID-19.https://www.who.int/director-general/speeches/detail/who-director-genera... Retrieved from.
    2. With more than 118,000 cases, the director of the WHO officially declared the COVID-19 pandemic.

    1. Al Sulayyim H.J., Khorshid S.M., Al Moummar S.H. Demographic, clinical, and outcomes of confirmed cases of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in Najran, Kingdom of Saudi Arabia (KSA); A retrospective record based study. J Infect Publ Health. 2020;13:1342–1346. doi: 10.1016/j.jiph.2020.04.007. - DOI - PMC - PubMed
    2. The author of this investigation reports different clinical presentations of other coronaviruses such as MERS-CoV and the frequent gastrointestinal effects of patients, 13.7% of the overall cohort had diarrhea and 7.8% had abdominal pain.

Publication types